Sanjivani Parenteral Q3 Profit Jumps 38% on Export-Led Growth
● Feb 16, 2026
Sanjivani Parenteral Limited (BSE: 531569), a manufacturer of parenteral and oral solid dosage formulations across therapeutic areas including CNS, cardiovascular,...
